MGAM and prostate cancer: MG-H1 has been reported to promote ROS production and activate the NF-κB signaling pathway through interaction with the receptor RAGE, thereby facilitating the dedifferentiation and increased mineralization activity of osteoblasts, thus creating a microenvironment conducive to osteoblastic metastasis of prostate cancer cells [88].